All

API

FDF

Price

Services

Excipients

Enquiries

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Price
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

Qualit-E-SpeakPharma-Insert

X

Find drug development pipeline and deal Updates information

A collaboration with SCORR Marketing

All Data

Filters

refresh

×

FILTER DATA :

News Type

Company

Product Type

Deal Size

Upfront Payment

refresh

Product Type

Companies

OMass Therapeutics

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United Kingdom

Post An Enquiry

Drug Discovery Chemistry

Participation Not Confirmed

Update your events

OMass Therapeutics Announces £27.5 M Extended Series A Financing

Contact the Supplier

Lead Product(s): Undisclosed

Therapeutic Area: Immunology

Highest Development Status: Undisclosed Product Type: Small molecule

Partner/Sponsor/Collaborator: Syncona

Deal Size: $53.6 million Upfront Cash: Undisclosed

Deal Type: Series A Financing February 17, 2020

Details:

Proceeds from this financing will allow the Company to progress a pipeline of small molecule therapeutics for patients suffering from immunological and genetic disorders.

Avacta Group

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United Kingdom

Post An Enquiry

Drug Discovery Chemistry

Participation Not Confirmed

Update your events

Avacta and Daewoong collaborate with AffyXell Therapeutics

Contact the Supplier

Lead Product(s): Stefin A

Therapeutic Area: Immunology

Highest Development Status: Undisclosed Product Type: Large molecule

Partner/Sponsor/Collaborator: AffyXell Therapeutics

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Collaboration February 03, 2020

Details:

License agreement to utilise Affimer® proteins in next generation cell and gene therapies.